Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
11/1995
11/15/1995EP0551434B1 High affinity tamoxifen derivatives and uses thereof
11/15/1995EP0431146B1 Radionuclide metal chelates for the radiolabeling of proteins
11/15/1995CN1111621A Boronic acid adducts of rhenium dioxime and technetium-99m dioxime complexes containing a biochemically active group
11/14/1995US5466434 Monitoring human breath for labeled carbon dioxide after feeding labeled triglycerides
11/09/1995WO1995029925A1 Thioether compounds for use in preparing bifunctional chelating agents for therapeutic radiopharmaceuticals
11/09/1995WO1995029924A1 Phosphonated polypyridyl compounds and their complexes
11/09/1995WO1995029916A1 Electron-deficient porphyrins and processes and intermediates for preparing same
11/09/1995WO1995029708A1 TECHNETIUM-99m LABELED IMAGING AGENTS
11/09/1995WO1995029707A1 Composition for delivery of toxic radioisotopes to the cell nucleus and use
11/09/1995WO1995029706A1 TIN-117m-CONTAINING RADIOTHERAPEUTIC AGENTS
11/09/1995WO1995029702A1 Texaphyrin solid-supports and devices
11/09/1995WO1995029669A2 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
11/09/1995CA2189420A1 Technetium-99m labeled imaging agents
11/09/1995CA2188569A1 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
11/09/1995CA2188565A1 Thioether compounds for use in preparing bifunctional chelating agents for therapeutic radiopharmaceuticals
11/09/1995CA2187949A1 Electron-deficient porphyrins and processes and intermediates for preparing same
11/08/1995EP0680340A1 Amplified direction of effector groups to specific target cells in an animal
11/08/1995EP0680335A1 Sequential targeting of tumor sites with oligonucleotide conjugates of antibody and complementary oligonucleotide conjugates of chelated radionuclide
11/08/1995EP0434765B1 Targeting substance-diagnostic/therapeutic agent conjugates having schiff base linkages
11/07/1995US5464934 Metal chelates as spacer compounds in biologically active peptides
11/07/1995US5464013 Medical scanning and treatment system and method
11/02/1995WO1995029236A2 Lymphocyte activation antigens and antibodies thereto
11/02/1995WO1995029180A1 Porphocyanine and cnc-expanded porphyrins
11/02/1995WO1995028968A1 Diagnostic image analysis with metal complexes
11/02/1995WO1995028967A1 Contrast agents
11/02/1995WO1995028966A1 Dendrimeric compounds
11/02/1995WO1995028948A1 Compositions comprising dna damaging agents and p53
11/02/1995EP0679162A1 Thrombus detection using radiolabelled disintegrins
11/02/1995DE19515401A1 [1,3-·1··4·C¶2¶]-Glycerin-nitrate und Verfahren zu deren Herstellung sowie diese enthaltende Lösungen [1,3 ·· · 1 · 4 C¶2¶] -glycerol-nitrate and methods for their preparation and to solutions containing
11/02/1995CA2188530A1 Diagnostic image analysis with metal complexes
11/02/1995CA2188292A1 Contrast agents
11/02/1995CA2187921A1 Dendrimeric compounds
10/1995
10/31/1995US5462725 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
10/25/1995EP0294392B1 Diagnostic and therapeutic antibody conjugates
10/24/1995US5460785 Direct labeling of antibodies and other protein with metal ions
10/19/1995WO1995027701A1 Metal-containing steroid mimics and ligands useful in the preparation thereof
10/19/1995CA2187749A1 Microfluidization of calcium/oxyanion-containing particles
10/17/1995US5459240 Genetic engineering of proteins
10/17/1995US5459159 Anticarcinogenic/antitumor agents; allowing accumulation in abnormal cells, irradiation with light of specified wavelength
10/17/1995US5458869 Multinuclear complexes for X-ray imaging
10/17/1995US5458127 Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
10/12/1995WO1995027075A1 Biological markers of benign prostate hyperplasia
10/12/1995WO1995026754A1 Segmented chelating polymers as imaging and therapeutic agents
10/12/1995WO1995022996A3 Peptide-chelator conjugates
10/12/1995CA2186861A1 Biological markers of benign prostate hyperplasia
10/12/1995CA2185812A1 Segmented chelating polymers as imaging and therapeutic agents
10/11/1995EP0675904A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus
10/11/1995EP0675737A1 Immunoreactive reagents employing dihydrofolate reductase
10/11/1995EP0397700B1 Sf-25 colon adenocarcinoma antigen, and antibodies which recognize this antigen
10/10/1995US5457323 Process for stripping radon-220 from radioactive isotope mixture
10/10/1995US5457207 Spirovesamicols
10/10/1995US5457183 Radiosensitizers
10/10/1995US5457177 Thrombin receptor radioligands
10/10/1995US5456900 Low density microspheres and their use as contrast agents for computed tomography
10/10/1995US5456663 Drugs and methods for treating diseases
10/05/1995WO1995026206A1 Method for preparing radionuclide-labeled chelating agent-ligand complexes
10/05/1995WO1995026205A1 Liposomes
10/05/1995CA2185810A1 Liposomes
10/04/1995EP0674710A1 Peptides and anti-sense peptides with broad neoplastic specificity
10/04/1995EP0674530A1 Polyhydric phenol compounds
10/04/1995CN1109469A Macrocyclic bifunctional chelants, complexes threof and their antibody conjugates
10/03/1995US5455158 Imaging fibrin-containing substance using labeled polypeptide imaging agent which binds to fibrin
10/03/1995US5455031 Polypeptide with 46 Kdalton HMFG differentiation antigen binding specificity, composition, kit and diagnostic method
10/03/1995US5455021 Isotopic tracer composition and method for making and using same
09/1995
09/28/1995WO1995025763A1 Branched polyoxaalkyl macromolecules, process for making them and their uses
09/28/1995WO1995025720A1 Piperidyl-4-substituted thyrosine derivatives as scintigraphic imaging agents for the diagnosis of thrombosis
09/28/1995CA2185647A1 Branched polyoxaalkyl macromolecules, process for making them and their uses
09/26/1995US5453269 Heterobifunctional antibodies having dual specificity for fibrin and thrombolylic agents and methods of use
09/21/1995WO1995025128A1 Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same
09/21/1995WO1995025119A1 Stabilization of peptides and proteins for radiopharmaceutical use
09/21/1995WO1995021601A3 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
09/21/1995CA2185663A1 Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same
09/20/1995EP0672673A1 Non-cyclic chelating agents based on aminodialkylphosphoros oxides for the preparation of technetium or rhenium complexes
09/20/1995EP0672253A1 Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor
09/20/1995EP0671927A1 Human neutralizing monoclonal antibodies to respiratory syncytial virus
09/20/1995EP0429644B1 Chelating agents for attaching metal ions to proteins
09/19/1995US5451576 Tumor imaging and treatment by water soluble texaphyrin metal complexes
09/16/1995CA2144588A1 Acyclic chelating agents based on aminodialkylphosphoric oxides for the preparation of technetium or rhenium complexes
09/14/1995WO1995024225A1 Polychelants
09/14/1995WO1995024221A1 Bioactive and/or targeted dendrimer conjugates
09/14/1995CA2181070A1 Polychelants
09/13/1995EP0670826A1 Fatty acid derivatives and pharmaceutical compositions containing them
09/13/1995EP0670736A1 Labelled interleukin-8 and medical uses thereof
09/12/1995US5449761 Labels and medical diagnosis
09/12/1995US5449663 L-Glucose
09/06/1995EP0670167A1 Receptor mediated endocytosis type diagnostic agents
09/06/1995EP0669913A1 Detection of hypoxia
08/1995
08/31/1995WO1995022996A2 Peptide-chelator conjugates
08/31/1995CA2182670A1 Peptide-chelator conjugates
08/30/1995EP0668777A1 Prostate-specific membrane antigen
08/30/1995EP0668775A1 Purified tsh preparation, process for its production and its use for the production of tsh tracers for tsh receptor assays and in tsh receptor assays
08/29/1995CA1336827C 8-hydroxyquinoline chelating agents
08/24/1995WO1995022611A2 Methods and compositions for stimulating bone cells
08/24/1995WO1995022544A2 Substituted 1,3,8-triaza-spiro(4,5)-decan-4-one derivatives useful as preliminary stages in the production of pharmaceuticals
08/24/1995WO1995022527A1 4,4-disubstituted piperidine derivatives useful as four-pointed ligands for complexing nuclides in nuclear medicine
08/24/1995WO1995022341A1 Labelled peptide compounds
08/24/1995WO1995013374A3 Human and mouse very low density lipoprotein receptors and methods for use of such receptors
08/24/1995DE4405178A1 Substituierte 1,3,8-Triaza-spiro(4,5)-decan-4-on-Derivate als Vorstufen zur Herstellung von Pharmazeutika Substituted 1,3,8-triaza-spiro (4,5) decan-4-one derivatives as precursors for the preparation of pharmaceuticals
08/24/1995DE4405140A1 Komplexbildner für in der Nuklearmedizin einsetzbare Nuklide, Verfahren zur Herstellung der Komplexe, sowie Diagnostikum enthaltend diese Komplexe Complexing of usable in nuclear medicine nuclides, process for the preparation of the complexes, as well as a diagnostic agent containing said complex
08/24/1995CA2183421A1 Labelled peptide compounds
1 ... 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 ... 243